Volume 18, Issue 5 (Sep-Oct 2024)                   mljgoums 2024, 18(5): 14-17 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Elgaily I, A. Abdrabo A. Comparison of glycated albumin and glycated Hemoglobin in type 2 diabetic patients with end-stage of renal disease. mljgoums 2024; 18 (5) :14-17
URL: http://mlj.goums.ac.ir/article-1-1566-en.html
1- Department of Clinical Chemistry, Faculty of Medical Laboratory Science, Al-Neelain University, Khartoum, Sudan
2- Department of Clinical Chemistry, Faculty of Medical Laboratory Science, Al-Neelain University, Khartoum, Sudan , abdrabokarim@hotmail.com
Abstract:   (527 Views)
Background: Various analytes are used to assess glycemic control in laboratory medicine. Glucose measurements show current glucose levels, but sample stability can be influenced by diet and stress. Hemoglobin A1c (HbA1c) is the best marker for long-term control but can be affected by elevated urea levels. This study compared glycated albumin (GA) and HbA1c in diabetic patients undergoing hemodialysis.
Methods: A comparative cross-sectional study was conducted with a sample size of 280 volunteers. Among these, there were 115 diabetic patients with end-stage renal disease (ESRD), 95 diabetic patients without ESRD, and 75 non-diabetic patients with ESRD. Laboratory measurements included HbA1c, GA, urea, and creatinine, assessed using standard laboratory techniques. Data analysis was carried out using SPSS statistical software.
Results: Levels of HbA1c were lower in diabetic patients with ESRD compared to diabetic patients without ESRD. In contrast, GA levels were higher in diabetics with ESRD. A significant negative association was observed between HbA1c levels and urea levels. However, creatinine levels were not associated with either HbA1c or GA.
Conclusion: The estimation of glycated hemoglobin levels can be affected by high blood urea. Therefore, GA may be a better glycemic indicator for diabetic patients with ESRD.
Full-Text [PDF 361 kb]   (235 Downloads) |   |   Full-Text (HTML)  (11 Views)  
Research Article: Research Article | Subject: Laboratory Sciences
Received: 2023/08/21 | Accepted: 2024/02/15 | Published: 2025/04/16 | ePublished: 2025/04/16

References
1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care. 2014; 37(Supplement_1): S81-S90. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Winocour PH. Diabetes and chronic kidney disease: an increasingly common multi‐morbid disease in need of a paradigm shift in care. Diabetic Medicine, 2018; 35(3): 300-305. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Vaidya SR, Aeddula NR. Chronic Kidney Disease. 2024 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. [View at Publisher] [PMID] [Google Scholar]
4. Cobo G, Lindholm B, Stenvinkel P. Chronic inflammation in end-stage renal disease and dialysis. Nephrology Dialysis Transplantation. 2018; 33(suppl_3): iii35-40. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis. 2014; 64(4): 510-33. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Suo M, Wen D, Wang W, Zhang T. Comparative study on hemoglobin A1c, glycated albumin and glycosylated serum protein in aplastic anemia patients with Type 2 diabetes mellitus. Bioscience Reports. 2020; 40(5): BSR20192300. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Neelofar K, Ahmad J. Amadori albumin in diabetic nephropathy. Indian journal of endocrinology and metabolism. 2015; 19(1): 39. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Selvin E, Sacks DB. Monitoring glycemic control in end-stage renal disease: what should be measured?. Clinical chemistry. 2017; 63(2): 447-449. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Shimizu I, Kohzuma T, Koga M. A proposed glycemic control marker for the future: glycated albumin. J Lab Precis Med. 2019; 4: 23. [View at Publisher] [DOI] [Google Scholar]
10. Gillery P. A history of HbA1c through clinical chemistry and laboratory medicine. Clinical Chemistry and Laboratory Medicine (CCLM). 2013; 51(1): 65-74. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Leow MKS. Glycated hemoglobin (HbA1c): clinical applications of a mathematical concept. Acta Informatica Medica. 2016; 24(4): 233. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Haque KS, Siddiqui MR. Clinical significance of glycated hemoglobin (HbA1c). Anwer Khan Modern Medical College Journal. 2013; 4(1): 3-5. [DOI] [Google Scholar]
13. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker insights. 2016; 11: BMI-S38440. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Parrinello CM, Selvin E. Beyond hba1c and glucose: The role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. Curr Diab Rep. 2014; 14: 548. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Cohen MP, Hud E. Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA. Journal of immunological methods. 1989; 122(2): 279-83. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Chutani A, Pande S. Correlation of serum creatinine and urea with glycemic index and duration of diabetes in Type 1 and Type 2 diabetes mellitus: A comparative study. National Journal of Physiology, Pharmacy and Pharmacology. 2017; 7(9): 914-914. [View at Publisher] [DOI] [Google Scholar]
17. Eckerbom S, Bergqvist Y, Jeppsson JO. Improved method for analysis of glycated haemoglobin by ion exchange chromatography. Annals of clinical biochemistry. 1994; 31(4): 355-60. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. Journal of Diabetes and its Complications. 2010; 24(2): 84-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Drechsler C, Krane V, Ritz E, März W, Wanner C. Glycemic control and cardiovascular events in diabetic hemodialysis patients. Circulation. 2009; 120(24): 2421-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Hashmi MF, Benjamin O, Lappin SL. End-Stage Renal Disease. In: StatPearls. StatPearls Publishing, Treasure Island (FL); 2023. PMID: 29763036. [View at Publisher] [Google Scholar]
21. Rhee CM, Leung AM, Kovesdy CP, Lynch KE, Brent GA, Kalantar‐Zadeh K. Updates on the management of diabetes in dialysis patients. In Seminars in dialysis. 2014; 27(2): 135-145. [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Li Q, Ju Y, Jin T, Pang B, Deng J, Du T, Wang H. Haemoglobin A₁c measurement in patients with chronic kidney disease. Clin Biochem. 2014; 47(6): 481-4. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Ly J, Marticorena R, Donnelly S. Red blood cell survival in chronic renal failure. Am J Kidney Dis. 2004; 44(4): 715-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Yang X, Zhao B, Wang J, Wang L, Tao M, Lu J, et al. Red blood cell lifespan in long-term hemodialysis patients treated with roxadustat or recombinant human erythropoietin. Renal Failure. 2021; 43(1): 1428-36. [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Inaba M, Okuno S, Kumeda Y et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol. 2007; 18: 896-903. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. Freedman BI, Shenoy RN, Planer JA, Clay KD, Shihabi ZK, Burkart JM, Cardona CY, Andries L, Peacock TP, Sabio H, Byers JR. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Peritoneal Dialysis International. 2010; 30(1): 72-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
27. Little RR, Rohlfing CL, Tennill AL, Hanson SE, Connolly S, Higgins T, et al. Measurement of HbA(1c) in patients with chronic renal failure. Clin Chim Acta. 2013; 418: 73-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
28. Herruer MH, van Kooten EA, Sluiter HE, Zuijderhoudt FM. Influence of uraemia on the determination of blood glycohaemoglobin by HPLC, electrophoresis and affinity chromatography. In diabetic and non-diabetic patients. Eur J Clin Chem Clin Biochem. 1994; 32:361-364. [View at Publisher] [DOI] [PMID] [Google Scholar]
29. Khashoggi H, Pignalosa S, Russo C, Pieri M, Bernardini S. New HPLC instrument performance evaluation in HbA1c determination and comparison with capillary electrophoresis. Scandinavian Journal of Clinical and Laboratory Investigation. 2018; 78(5): 393-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
30. Zubair, M., Malik, A. and Ahmad, J.,. Correlation of HbA1c and S. creatinine along with microbiological profiling of infected ulcers; cases of diabetic patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019; 13(1): 30-34. [View at Publisher] [DOI] [PMID] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.